Carregant...
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
BACKGROUND: Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard adjuvant therapy in patients with stage III colon cancer. However, since oxaliplatin is associated with cumulative neurotoxicity, a shorter duration of therapy could spare toxic effe...
Guardat en:
| Publicat a: | N Engl J Med |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6426127/ https://ncbi.nlm.nih.gov/pubmed/29590544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1713709 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|